Just like shopping online for Christmas presents, the real hassle with providing drugs for NTDs is not finding the right supplier or best cost, it’s ensuring they arrive on time and in optimal condition. Pharmaceutical companies may have pledged billions of free vaccines for diseases in developing countries but these drugs cannot travel on good will alone. Continue reading
Gilead Sciences announces a five-year partnership with the World Health Organization (WHO) that aims to tackle visceral leishmaniasis (VL). The agreement will see the pharmaceutical company donating 445,000 vials of the drug AmBisome, which has been recommended as the safest, most effective treatment for VL. VL is widespread in South Asia and the Horn of Africa and has a mortality rate of almost 100 percent if it is not treated. Continue reading
The amount of money spent on tropical disease research fell in 2010, according to a report published by G-Finder.
Malaria was the hardest hit, but research into diarrhoeal disease, helminths (including worms and schistosomiasis), kinetoplastids (Chagas’ disease, leishmaniasis and sleeping sickness), leprosy and dengue fever fell. Continue reading
End the Neglect, blogging on behalf of the Global Network for Neglected Tropical Diseases, has started a new campaign to rid the world of seven of the most common NTDs. Follow their campaign at http://www.END7.org/
We’re at the beginning of something big.
Not many people know about neglected tropical diseases (NTDs) – a group of parasitic infections that cause needless suffering among more than 1 billion of the poorest people worldwide. END7 is a campaign to see the end of 7 of the most common NTDs by 2020. All it costs is 50 pence to treat and protect one person for one year!
Join us in our mission to end 7 diseases by 2020 – watch our mission in (just over) a minute below and Like us on Facebook. Together we can see the end!
An outbreak of Chikungunya in Delhi is accompanying an outbreak of dengue fever. Chikungunya is closely related to dengue and is carried by the same mosquito, but is far less common at the moment.
The Schistosomiasis Control Initiative came second in Give Well’s annual charity ratings. The SCI is also top of the list for Giving What We Can, a campaign founded by Oxford philosophy lecturer Toby Ord to persuade people to give a percentage of their earnings to charity.
Bangladesh has scrapped an Act which forced leprosy sufferers to live in institutions. Officials hope that social stigma attached to this treatable disease will be reduced, and people will be more willing to come forward for treatment.
And finally, it might be possible to treat Buruli ulcer with oral antibiotics, according to this paper in PLoS NTDs. At the moment, most Buruli cases are treated by surgical excision, requiring long periods in hospital.